BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25935919)

  • 1. 5-Fluorouracil cardiotoxicity: reversible left ventricular systolic dysfunction with early detection.
    Iskandar MZ; Quasem W; El-Omar M
    BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25935919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Fluorouracil-induced Tako-Tsubo-like syndrome.
    Basselin C; Fontanges T; Descotes J; Chevalier P; Bui-Xuan B; Feinard G; Timour Q
    Pharmacotherapy; 2011 Feb; 31(2):226. PubMed ID: 21275498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute reversible left ventricular systolic dysfunction associated with 5-fluorouracil therapy: a rare and increasingly recognised cardiotoxicity of a commonly used drug.
    Mishra T; Shokr M; Ahmed A; Afonso L
    BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31519717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-Fluorouracil cardiotoxicity: left ventricular dysfunction and effect of coronary vasodilators.
    Patel B; Kloner RA; Ensley J; Al-Sarraf M; Kish J; Wynne J
    Am J Med Sci; 1987 Oct; 294(4):238-43. PubMed ID: 3661619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Failure of oral nitrate and calcium channel blocker therapy to prevent 5-fluorouracil-related myocardial ischemia: a case report.
    Akpek G; Hartshorn KL
    Cancer Chemother Pharmacol; 1999; 43(2):157-61. PubMed ID: 9923822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Various Manifestations of 5-Fluorouracil Cardiotoxicity: A Multicenter Case Series and Review of Literature.
    Allison JD; Tanavin T; Yang Y; Birnbaum G; Khalid U
    Cardiovasc Toxicol; 2020 Aug; 20(4):437-442. PubMed ID: 31925673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe cardiotoxicity during 5-fluorouracil chemotherapy: a case and literature report.
    Kuropkat C; Griem K; Clark J; Rodriguez ER; Hutchinson J; Taylor SG
    Am J Clin Oncol; 1999 Oct; 22(5):466-70. PubMed ID: 10521060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angina induced by 5-fluorouracil infusion in a patient with normal coronaries.
    Tajik R; Saadat H; Taherkhani M; Movahed MR
    Am Heart Hosp J; 2010; 8(2):E111-2. PubMed ID: 21928176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capecitabine-induced cardiotoxicity: when to suspect? How to manage? A case report.
    Farina A; Malafronte C; Valsecchi MA; Achilli F
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):722-6. PubMed ID: 19584743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Coronary artery stenting in the treatment of 5-fluorouracil-induced unstable angina].
    Grześk G; Orzałkiewicz Z; Polak G; Przybył R; Nartowicz E; Szadujkis-Szadurski L; Grabczewska Z
    Przegl Lek; 2003; 60(1):46-8. PubMed ID: 12884648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of severe coronary spasm associated with 5-fluorouracil chemotherapy.
    Kim SM; Kwak CH; Lee B; Kim SB; Sir JJ; Cho WH; Choi SK
    Korean J Intern Med; 2012 Sep; 27(3):342-5. PubMed ID: 23019400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-fluorouracil-Induced cardiotoxicity.
    Shanmugasundaram S; Bharathithasan R; Elangovan S
    Indian Heart J; 2002; 54(1):86-7. PubMed ID: 11999096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capecitabine caused cardiogenic shock through induction of global Takotsubo syndrome.
    Y-Hassan S; Tornvall P; Törnerud M; Henareh L
    Cardiovasc Revasc Med; 2013; 14(1):57-61. PubMed ID: 23218901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial dose effect of 5-fluorouracil: rapidly improving severe, acute toxic myopericarditis.
    Çalık AN; Çeliker E; Velibey Y; Çağdaş M; Güzelburç Ö
    Am J Emerg Med; 2012 Jan; 30(1):257.e1-3. PubMed ID: 21208764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-Fluorouracil cardiotoxicity induced by alpha-fluoro-beta-alanine.
    Muneoka K; Shirai Y; Yokoyama N; Wakai T; Hatakeyama K
    Int J Clin Oncol; 2005 Dec; 10(6):441-3. PubMed ID: 16369751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute heart failure after treatment with 5-fluorouracil.
    Georgieva S; Kinova E; Iordanov V; Gudev A; Tzekova V; Velikova M
    J BUON; 2007; 12(1):113-6. PubMed ID: 17436411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of recovery time indexes in 5-fluorouracil-treated cancer patients.
    Orditura M; De Vita F; Sarubbi B; Ducceschi V; Auriemma A; Infusino S; Iacono A; Catalano G
    Oncol Rep; 1998; 5(3):645-7. PubMed ID: 9538168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of coronary spasm induced by 5-fluorouracil.
    Gorgulu S; Celik S; Tezel T
    Acta Cardiol; 2002 Oct; 57(5):381-3. PubMed ID: 12405579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy -- a survey of 427 patients.
    Tsavaris N; Kosmas C; Vadiaka M; Efremidis M; Zinelis A; Beldecos D; Sakelariou D; Koufos C; Stamatelos G
    Med Sci Monit; 2002 Jun; 8(6):PI51-7. PubMed ID: 12070449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute coronary syndrome induced by capecitabine therapy.
    Wijesinghe N; Thompson PI; McAlister H
    Heart Lung Circ; 2006 Oct; 15(5):337-9. PubMed ID: 16697705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.